A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol
Sogand Sadeghi, Ali Akbar Kiaei, Mahnaz Boush, Nader Salari, Masoud Mohammadi, Danial Safaei, Mitra Mahboubi, Arian Tajfam, Sabra Moghadam
The paper proposes a method using graph neural networks to recommend drug combinations for lung adenocarcinoma by targeting genes and proteins, finding Gefitinib, Paclitaxel, and Icotinib as the most effective combination.
medRxiv · Apr 14, 2024 · PreprintGenetic & Genomic Medicine